Beijing Biosis Healing biological technology Co., Ltd, found in 2012, is located in Daxing Biopharmaceutical Industry Base of Zhongguancun Science and Technology Park. The company is a qualified National High-tech Enterprise of China, an authorized post-doctoral research station. The core technique of the company is extracellular matrix material. The company has set up high level quality management system and GMP warkshop to produce multiple products, including of regeneration mediclal material, implantable repare devices and minimally invasive surgical devices, which all have independent intellectual property rights. The company is owning 21 PCT and international patents, 95 national patents of China. As an innovation and alive medical devices manufacture, the company is one of“TOP 100 Potential Companies of Science and Technology Innovation Board”,“2018 Top 50 Most Valuble Investment Companies”and“2019 Most Innovative Enterprise”in China.
To fight against COVID-19, the company took its social responsiblility to develope and munufacture protective products from the first time. Taking the advantage of 3000 M2 GMP workshop and the experience of high level qulity control at Class II and III medical devices manufacturing, the company set up production lines of medical surgical maskes, medical protective coverall, isolation gown, medical protective masks and FFP2/FFP3 masks in short time. The protective products passed both domestic and international test, got international as well as NMPA certificates, and are in the white list of Chinese Ministry of Commerce. So all products can be exported freely to help global epidemic prevention.
Beijing Biosis Healing biological technology Co., Ltd, found in 2012, is located in Daxing Biopharmaceutical Industry Base of Zhongguancun Science and Technology Park. The company is a qualified National High-tech Enterprise of China, an authorized post-doctoral research station. The core technique of the company is extracellular matrix material. The company has set up high level quality management system and GMP warkshop to produce multiple products, including of regeneration mediclal material, implantable repare devices and minimally invasive surgical devices, which all have independent intellectual property rights. The company is owning 21 PCT and international patents, 95 national patents of China. As an innovation and alive medical devices manufacture, the company is one of“TOP 100 Potential Companies of Science and Technology Innovation Board”,“2018 Top 50 Most Valuble Investment Companies”and“2019 Most Innovative Enterprise”in China.
To fight against COVID-19, the company took its social responsiblility to develope and munufacture protective products from the first time. Taking the advantage of 3000 M2 GMP workshop and the experience of high level qulity control at Class II and III medical devices manufacturing, the company set up production lines of medical surgical maskes, medical protective coverall, isolation gown, medical protective masks and FFP2/FFP3 masks in short time. The protective products passed both domestic and international test, got international as well as NMPA certificates, and are in the white list of Chinese Ministry of Commerce. So all products can be exported freely to help global epidemic prevention.